Turkey is a notable destination for Adenocarcinoma treatment, with hospitals accredited by the Joint Commission International. Facilities like Anadolu Medical Center, Memorial Şişli Hospital, and Medipol Mega University Hospital offer robotic surgery, targeted therapy, and immunotherapy. Anadolu Medical Center, affiliated with Johns Hopkins Hospital, is known for advanced oncology services. Memorial Şişli Hospital, the first JCI-accredited in Turkey, has a 90% success rate in organ transplants and leads in oncology.
The survival rate for Adenocarcinoma in Turkey reaches 70%, with robotic surgery, targeted therapy, immunotherapy, and minimally invasive surgery contributing to this. Medipol Mega University Hospital uses technologies like the Da Vinci Surgical System and CyberKnife, enhancing cancer treatment precision and effectiveness. These hospitals provide personalized care and high success rates, making Turkey a favorable option for international patients seeking Adenocarcinoma treatment.